Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens

NCT00994344 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Darunavir/ritonavir
DRUG: Lopinavir/ritonavir

Sponsor

Germans Trias i Pujol Hospital